By Izzy Wood (Drug Target Review)2023-06-08T15:00:39
Japanese researchers now reveal a new way of activating GPCR by triggering shape changes in the intracellular region of the receptor. This new process can help researchers design drugs with fewer or no side effects.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-07-10T06:15:00Z
Contributor Professor Donald E Ingber, By Drug Target Review
2026-07-08T12:00:00Z
2026-07-07T12:00:00Z
2026-05-25T07:00:00
Contributor Professor Neville Sanjana
2026-06-15T11:00:00
Sponsored by Miltenyi Biotec
2023-01-05T14:41:33
Sponsored by Cell Signaling Technology
2026-05-22T07:38:00
Contributor Dr Helen Bright, By Drug Target Review
2024-01-09T10:09:08
Sponsored by Sartorius iQue®
2024-01-10T08:56:17
Sponsored by Leica Microsystems
Site powered by Webvision Cloud